To compare the in vitro activity of 3 popular fluoroquinolones against common respiratory and middle ear pathogens
Abstract
Antibiotic resistance among respiratory tract pathogens is increasing worldwide. Beta-lactam-resistant as well as macrolide and fluoroquinolone-resistant strains of the commonest pathogens are being isolated with increasing frequency in manycountries . In case of ear infections, bacteria account for about 85% of cases of otitis media. Viruses account for the remaining 15%.
Read the paper
Related studies
- Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing
- Laboratory-based nationwide surveillance of antimicrobial resistance in Ghana
- Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains
- Incidence and factors associated with development of phlebitis: results of a pilot study cohort
- Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
- Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pyloriEradication in Taiwan
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.